PRE-DETERMINEコホート研究
PRE-DETERMINE: 生物学的マーカーと MRI SCD コホート研究
This is a prospective, multi-center cohort study of patients with a history of coronary artery disease (CAD) and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%). The primary objective of this study is to determine whether biologic markers and ECGs can be utilized to advance SCD risk prediction in patients with CHD and LVEF>30-35%. The overarching goal of the study is to identify a series of markers that alone or in combination specifically predict risk of arrhythmic death as compared to other causes of mortality among this at risk population of coronary heart disease (CHD) patients with preserved left ventricular ejection fraction (LVEF> 30-35%). If biologic or ECG markers are identified that can specifically predict risk of ventricular arrhythmias, then these markers may serve as relatively inexpensive methods to identify those at risk. The public health impact of identifying markers could be quite substantial, leading to more efficient utilization of ICDs and advances in our understanding of mechanisms underlying SCD.
調査の概要
詳細な説明
The PRE-DETERMINE Study is a prospective, multi-center study of patients with a history of coronary artery disease (CAD) and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%). Patients were enrolled at 135 sites where information on baseline demographics, clinical characteristics, pertinent past medical history, lifestyle habits, cardiac test results, and medications were collected via electronic data capture. Electrocardiograms along with a blood sample was also collected at baseline, sent to central laboratories, and stored for future analyses. Contrast-enhanced magnetic resonance imaging (CE-MRI) scans were collected on a subset of patients and analyzed. Enrollment closed in November 2013 and patients are now being followed centrally by the Clinical Coordinating Center via mail/phone to document interim non-fatal arrhythmic events and cause-specific mortality. Questionnaires that inquire about intervening ICD implantations, ICD therapies, cardiac arrest, and other pertinent cardiovascular endpoints are mailed to participants every six months, and follow-up telephone calls are made to non-responders. Study endpoints are being confirmed through review of medical records, interviews with next-of-kin, and autopsy reports, if available.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
Alaska
-
Anchorage、Alaska、アメリカ、99508
- Alaska Heart Institute
-
-
Arizona
-
Glendale、Arizona、アメリカ、85306
- Phoenix Heart, PLLC
-
Phoenix、Arizona、アメリカ、85032
- Cardiovascular Consultants
-
-
California
-
Banning、California、アメリカ、92220
- Beaver Medical Group/Clinical Care Research
-
-
Colorado
-
Colorado Springs、Colorado、アメリカ、80909
- Memorial Health System
-
Denver、Colorado、アメリカ、80204
- Colorado Heart and Vascular
-
-
Florida
-
Brandon、Florida、アメリカ、33511
- Bay Area Cardiology Associates, P.A.
-
Gainesville、Florida、アメリカ、32610
- University of Florida - Gainsville
-
Miami、Florida、アメリカ、33135
- Reliable Clinical Research
-
Miami Beach、Florida、アメリカ、33140
- Mount Sinai Medical Center
-
Orlando、Florida、アメリカ、32804
- Florida Hospital
-
Orlando、Florida、アメリカ、32806
- Orlando Regional Medical Center
-
Palm Beach Gardens、Florida、アメリカ、33410
- Palm Beach Gardens Research Center
-
Sarasota、Florida、アメリカ、34233
- Velella Research
-
Tallahassee、Florida、アメリカ、32308
- Tallahassee Research Institute, Inc.
-
West Palm Beach、Florida、アメリカ、33401
- Cardiology Associates of Palm Beach - West Palm Beach
-
-
Georgia
-
Covington、Georgia、アメリカ、30014
- Georgia Heart Specialist
-
Gainesville、Georgia、アメリカ、30501
- Northeast Georgia Heart Center, P.C.
-
-
Illinois
-
Chicago、Illinois、アメリカ、60637
- University of Chicago
-
Chicago、Illinois、アメリカ、60643
- Advocate Medical Group
-
Chicago、Illinois、アメリカ、60657
- Advocate Medical Group - Heart and Vascular of IL
-
Melrose Park、Illinois、アメリカ、60160
- Consultants in Cardiovascular Medicine
-
-
Indiana
-
Anderson、Indiana、アメリカ、46011
- Community Heart and Vascular
-
-
Iowa
-
West Des Moines、Iowa、アメリカ、50266
- Iowa Heart Center
-
-
Kansas
-
Kansas City、Kansas、アメリカ、66160
- The University of Kansas
-
-
Kentucky
-
Lexington、Kentucky、アメリカ、40503
- Baptist Health Lexington
-
-
Louisiana
-
Houma、Louisiana、アメリカ、70363
- Leonard J. Chabert Medical Center
-
-
Maine
-
Auburn、Maine、アメリカ、04210
- Maine Research Associates
-
Lewiston、Maine、アメリカ、04240
- Maine Research Associates - Lewiston
-
-
Maryland
-
Baltimore、Maryland、アメリカ、21201
- University of Maryland Medical Center
-
-
Massachusetts
-
Ayer、Massachusetts、アメリカ、01432
- Primary Care Cardiology Research
-
Boston、Massachusetts、アメリカ、02115
- Brigham and Women's Hospital
-
Fall River、Massachusetts、アメリカ、02720
- NECCR Internal Medicine and Cardiology Associates, LLC
-
North Dartmouth、Massachusetts、アメリカ、02747
- Hawthorn Medical Associates
-
Springfield、Massachusetts、アメリカ、01199
- Baystate Cardiology
-
-
Michigan
-
Ann Arbor、Michigan、アメリカ、48109
- University of Michigan Medical Center
-
Dearborn、Michigan、アメリカ、48124
- Oakwood Hospital & Medical Center
-
Mount Clemens、Michigan、アメリカ、48043
- McLaren Medical Center - Macomb
-
Ypsilanti、Michigan、アメリカ、48197
- Michigan Heart
-
-
Minnesota
-
Minneapolis、Minnesota、アメリカ、55417
- Minneapolis VA Medical Center
-
-
Missouri
-
Columbia、Missouri、アメリカ、65201
- University of Missouri Health Care
-
-
Montana
-
Kalispell、Montana、アメリカ、59901
- Glacier View Cardiology
-
-
Nebraska
-
Omaha、Nebraska、アメリカ、68131
- The Cardiac Center of Creighton University
-
-
New Jersey
-
Bridgewater、New Jersey、アメリカ、08807
- Advanced Heartcare, LLC
-
Paterson、New Jersey、アメリカ、07503
- St. Joseph Regional Medical Center
-
-
New Mexico
-
Albuquerque、New Mexico、アメリカ、87108
- New Mexico VA Healthcare Systems
-
-
New York
-
Albany、New York、アメリカ、12205
- Albany Associates Cardiology
-
Brooklyn、New York、アメリカ、11219
- Maimonides Medical Center
-
Buffalo、New York、アメリカ、14203
- Buffalo General Hospital/Kaleida Health
-
Jamaica、New York、アメリカ、11418
- Jamaica Hospital Medical Center
-
Kingston、New York、アメリカ、12401
- Mid-Valley Cardiology
-
Mineola、New York、アメリカ、11501
- Winthrop-University Hospital
-
New York、New York、アメリカ、10001
- Gotham Cardiovascular
-
New York、New York、アメリカ、10032
- Columbia University Health Center
-
Stony Brook、New York、アメリカ、11794
- Stony Brook University Medical Center
-
Utica、New York、アメリカ、13501
- St. Elizabeth Medical Center - Hotvedt
-
-
North Carolina
-
Asheville、North Carolina、アメリカ、28801
- Asheville Cardiology Associates
-
Elizabeth City、North Carolina、アメリカ、27909
- Eastern Carolina Cardiovascular
-
Lenoir、North Carolina、アメリカ、28645
- Northstate Clinical Research
-
Pinehurst、North Carolina、アメリカ、28374
- Pinehurst Medical Clinic, Inc.
-
Sanford、North Carolina、アメリカ、27330
- Sanford Cardiology
-
Winston-Salem、North Carolina、アメリカ、27157
- Wake Forest
-
-
Ohio
-
Akron、Ohio、アメリカ、44304
- Northeast Ohio Cardiovascular Specialists
-
Cincinnati、Ohio、アメリカ、45267
- University of Cincinnati
-
Cleveland、Ohio、アメリカ、44109
- MetroHealth Medical Center
-
Elyria、Ohio、アメリカ、44035
- North Ohio Research, Ltd.
-
Fairfield、Ohio、アメリカ、45014
- Mercy Medical Associates
-
Toledo、Ohio、アメリカ、43615
- Northwest Ohio Cardiology Consultants/The Toledo Hospital
-
-
Oklahoma
-
Oklahoma City、Oklahoma、アメリカ、73120
- Oklahoma Foundation for Cardiovascular Research
-
Oklahoma City、Oklahoma、アメリカ、73104
- Oklahoma City VA Medical Center Veterans Research and Education Foundation
-
-
Pennsylvania
-
Abington、Pennsylvania、アメリカ、19001
- Abington Memorial Hospital
-
Bethlehem、Pennsylvania、アメリカ、18018
- St. Luke's Bethlehem
-
Doylestown、Pennsylvania、アメリカ、18901
- Doylestown Cardiology Associates
-
Pittsburgh、Pennsylvania、アメリカ、15212
- Allegheny General Hospital
-
Pittsburgh、Pennsylvania、アメリカ、15213
- University of Pittsburgh Medical Center
-
-
South Carolina
-
Anderson、South Carolina、アメリカ、29621
- AnMed Health
-
Charleston、South Carolina、アメリカ、29425
- VA Medical Center - Charleston
-
Rock Hill、South Carolina、アメリカ、29732
- Carolina Cardiology Associates
-
-
South Dakota
-
Rapid City、South Dakota、アメリカ、57701
- Black Hills Cardiovascular Research
-
-
Tennessee
-
Knoxville、Tennessee、アメリカ、37917
- Cardiovasular Research of Knoxville
-
Memphis、Tennessee、アメリカ、38104
- Memphis VA Medical Center
-
-
Texas
-
Houston、Texas、アメリカ、77030
- St. Luke's Episcopal Hospital
-
Houston、Texas、アメリカ、77074
- Non-Invasive Cardiovascular PA
-
Waco、Texas、アメリカ、76712
- Providence Health Center
-
-
Utah
-
Murray、Utah、アメリカ、84157
- Intermountain Medical Center
-
-
Virginia
-
Virginia Beach、Virginia、アメリカ、23454
- Cardiovascular Associates Virginia Beach
-
-
-
-
Alberta
-
Edmonton、Alberta、カナダ、T6G 2B7
- University of Alberta
-
-
British Columbia
-
Vancouver、British Columbia、カナダ、V5Z 1M9
- Vancouver General Hospital
-
-
Ontario
-
Mississauga、Ontario、カナダ、L5B 2P7
- Mississauga Clinical Research Centre
-
-
-
-
-
Rio Piedras、プエルトリコ、00924
- Transcatheter Medical, Inc. Centro Cardiovascular de Caguas y del Caribe
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
Participants have been recruited throughout multicenter sites participating in the PRE-DETERMINE Cohort Study. Patients with a history of coronary artery disease and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%) have been enrolled. The clinical study staff at each site, which was either a research nurse, fellow, or physician approached eligible patients to discuss their potential participation.
説明
Inclusion Criteria:
-
Evidence of Coronary Artery Disease (CAD) a or documented prior Myocardial Infarction.
-
LVEF >35% by any current standard evaluation technique (e.g.,) echocardiogram, MUGA, angiography). 2.1. Patients who have an LVEF between 30-35% and NYHA Class I heart failure who do not have history of ventricular tachyarrhythmias,or inducible ventricular tachycardia during electrophysiological (EP) testing can be enrolled.
-
If documented prior MI is not present, evidence of mild-moderate systolic Left Ventricular Dysfunction with an EF >35- ≤50% as measured by any current standard screening technique (e.g.,echocardiogram, MUGA, angiography) must be present.
-
Patients aged 18 years or above
-
CAD will be defined as evidence of one of the following two (2) criteria:
- Significant stenosis of a major epicardial vessel (>50% proximal or 70% distal) by coronary angiography
- Prior revascularization (percutaneous coronary intervention or coronary artery bypass surgery)
-
MI can be documented in the following ways:
-
From the MI hospitalization: Detection of a rise and fall of cardiac biomarkers > 99th percentile of lab (e.g., CPK elevation or Troponin at least > two times the upper limit of normal) together with myocardial ischemia with at least one of the following:
- Symptoms of Ischemia
- ECG changes indicative of new ischemia (new ST-T changes or new LBBB)
- Development of pathological Q waves
- Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality
-
If no report from the MI hospitalization is available, prior MI can be met by either of the following:
- Development of pathological Q waves
- Imaging evidence of a region of loss of viable myocardium that is thinned and fails to contract, in the absence of a non-ischaemic cause
-
-
Exclusion Criteria:
- History of cardiac arrest or spontaneous or inducible sustained VT (15 beats or more at a rate of 120 BPM or greater - the occurrence of cardiac arrest or spontaneous VT in the setting of an acute MI is not considered an exclusion).
- Unexplained syncope
- Current or planned implantable cardiac defibrillator (ICD)
- Any condition other than cardiac disease that, in the investigator's judgment, would seriously limit life expectancy (poor survival)
- Metastatic cancer
- Marked valvular heart disease requiring surgical intervention
- Current or planned cardiac, renal or liver transplant
- Current alcohol or drug abuse
- Unwilling or unable to provide informed consent
- LVEF <35% with Class II-IV CHF or LVEF <30%
- Participation in a clinical trial where the active treatment arm is testing an agent and/or intervention with known antiarrhythmic properties
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:COHORT
- 時間の展望:PROSPECTIVE
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Sudden and/or arrhythmic cardiac death or resuscitated ventricular fibrillation.
時間枠:Median follow-up estimated to be 10.7 years
|
A definite sudden cardiac death (SCD) is defined as a death or fatal cardiac arrest occurring within 1 hour of symptom onset or the presence of autopsy consistent with SCD (e.g. acute coronary thrombosis). Probable SCD is defined as an unwitnessed death or death during sleep where the participant was observed to be symptom-free within the preceding 24 hours. Arrhythmic death is defined as the abrupt spontaneous collapse of circulation without antecedent circulatory or neurologic impairment. Deaths classified as non-arrhythmic are not included in the primary endpoint regardless of timing. Resuscitated ventricular fibrillation is defined as out-of-hospital cardiac arrests with documented VF and/or use of external electrical defibrillation for resuscitation. |
Median follow-up estimated to be 10.7 years
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
ICD 移植
時間枠:追跡調査の中央値は10.7年と推定される
|
追跡調査の中央値は10.7年と推定される
|
|
|
総心臓死亡率
時間枠:追跡調査の中央値は10.7年と推定される
|
追跡調査の中央値は10.7年と推定される
|
|
|
総死亡率
時間枠:追跡調査の中央値は10.7年と推定される
|
追跡調査の中央値は10.7年と推定される
|
|
|
ICD Shock
時間枠:Median follow-up estimated to be 10.7 years
|
ICD therapies for ventricular arrhythmias over 200 BPMs will be added to the endpoint. |
Median follow-up estimated to be 10.7 years
|
|
Non-Sudden or Arrhythmic Causes of Mortality
時間枠:Median follow-up estimated to be 10.7 years
|
Competing causes of mortality in competing risk analyses. |
Median follow-up estimated to be 10.7 years
|
協力者と研究者
協力者
捜査官
- 主任研究者:Christine M Albert, M.D., M.P.H.、Brigham and Women's Hospital
出版物と役立つリンク
一般刊行物
- Silverman MG, Yeri A, Moorthy MV, Camacho Garcia F, Chatterjee NA, Glinge CSA, Tfelt-Hansen J, Salvador AM, Pico AR, Shah R, Albert CM, Das S. Circulating miRNAs and Risk of Sudden Death in Patients With Coronary Heart Disease. JACC Clin Electrophysiol. 2020 Jan;6(1):70-79. doi: 10.1016/j.jacep.2019.08.011. Epub 2019 Oct 30.
- Lee DC, Albert CM, Narula D, Kadish AH, Panicker GK, Wu E, Schaechter A, Pester J, Chatterjee NA, Cook NR, Goldberger JJ. Estimating Myocardial Infarction Size With a Simple Electrocardiographic Marker Score. J Am Heart Assoc. 2020 Feb 4;9(3):e014205. doi: 10.1161/JAHA.119.014205. Epub 2020 Jan 24.
- Chatterjee NA, Tikkanen JT, Panicker GK, Narula D, Lee DC, Kentta T, Junttila JM, Cook NR, Kadish A, Goldberger JJ, Huikuri HV, Albert CM; PREDETERMINE Investigators. Simple electrocardiographic measures improve sudden arrhythmic death prediction in coronary disease. Eur Heart J. 2020 Jun 1;41(21):1988-1999. doi: 10.1093/eurheartj/ehaa177.
- Panicker GK, Narula DD, Albert CM, Lee DC, Kothari S, Goldberger JJ, Cook N, Schaechter A, Kim E, Moorthy MV, Pester J, Chatterjee NA, Kadish AH, Karnad DR. Validation of electrocardiographic criteria for identifying left ventricular dysfunction in patients with previous myocardial infarction. Ann Noninvasive Electrocardiol. 2021 Mar;26(2):e12812. doi: 10.1111/anec.12812. Epub 2020 Oct 30.
- Venkateswaran RV, Moorthy MV, Chatterjee NA, Pester J, Kadish AH, Lee DC, Cook NR, Albert CM. Diabetes and Risk of Sudden Death in Coronary Artery Disease Patients Without Severe Systolic Dysfunction. JACC Clin Electrophysiol. 2021 Dec;7(12):1604-1614. doi: 10.1016/j.jacep.2021.05.014. Epub 2021 Jul 28.
- Adabag S, Patton KK, Buxton AE, Rector TS, Ensrud KE, Vakil K, Levy WC, Poole JE. Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial. JAMA Cardiol. 2017 Jul 1;2(7):767-774. doi: 10.1001/jamacardio.2017.1413.
- Sandhu RK, Dron JS, Liu Y, Moorthy MV, Chatterjee NA, Ellinor PT, Chasman DI, Cook NR, Khera AV, Albert CM. Polygenic Risk Score Predicts Sudden Death in Patients With Coronary Disease and Preserved Systolic Function. J Am Coll Cardiol. 2022 Aug 30;80(9):873-883. doi: 10.1016/j.jacc.2022.05.049.
- Peek N, Hindricks G, Akbarov A, Tijssen JGP, Jenkins DA, Kapacee Z, Parkes LM, van der Geest RJ, Longato E, Sprague D, Taleb Y, Ong M, Miller CA, Shamloo AS, Albert C, Barthel P, Boveda S, Braunschweig F, Johansen JB, Cook N, de Chillou C, Elders P, Faxen J, Friede T, Fusini L, Gale CP, Jarkovsky J, Jouven X, Junttila J, Kautzner J, Kiviniemi A, Kutyifa V, Leclercq C, Lee DC, Leigh J, Lenarczyk R, Leyva F, Maeng M, Manca A, Marijon E, Marschall U, Merino JL, Mont L, Nielsen JC, Olsen T, Pester J, Pontone G, Roca I, Schmidt G, Schwartz PJ, Sticherling C, Suleiman M, Taborsky M, Tan HL, Tfelt-Hansen J, Thiele H, Tomaselli GF, Verstraelen T, Vinayagamoorthy M, Olesen KKW, Wilde A, Willems R, Wu KC, Zabel M, Martin GP, Dagres N. Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts. Eur Heart J. 2024 Nov 14;45(43):4616-4626. doi: 10.1093/eurheartj/ehae326.
- Chatterjee NA, Moorthy MV, Pester J, Schaecter A, Panicker GK, Narula D, Lee DC, Goldberger JJ, Kadish A, Cook NR, Albert CM; PRE-DETERMINE Study Group. Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction. JAMA Cardiol. 2018 Jul 1;3(7):591-600. doi: 10.1001/jamacardio.2018.1049.
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (推定)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
追加の関連 MeSH 用語
その他の研究ID番号
- 2007P000840
- R01HL091069 (米国 NIH グラント/契約)
- R01HL165840 (米国 NIH グラント/契約)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。